Terms: = Brain cancer AND MLLT3, AF9, 4300, ENSG00000171843, P42568, YEATS3, AF-9 AND Treatment
4 results:
1. An Isochroman Analog of CD3254 and Allyl-, Isochroman-Analogs of NEt-TMN Prove to Be More Potent Retinoid-X-Receptor (RXR) Selective Agonists Than Bexarotene.
Jurutka PW; di Martino O; Reshi S; Mallick S; Sausedo MA; Moen GA; Lee IJ; Ivan DJ; Krall TD; Peoples SJ; Perez A; Tromba L; Le A; Khadka I; Petros R; Savage BM; Salama E; Salama J; Ziller JW; Noh Y; Lee MY; Liu W; Welch JS; Marshall PA; Wagner CE
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555852
[TBL] [Abstract] [Full Text] [Related]
2. Physics and dosimetry of the gamma knife.
Wu A
Neurosurg Clin N Am; 1992 Jan; 3(1):35-50. PubMed ID: 1633451
[TBL] [Abstract] [Full Text] [Related]
3. Accelerated fractionation radiotherapy for hospitalized glioblastoma multiforme patients with poor prognostic factors.
Hernandez JC; Maruyama Y; Yaes R; Chin HW
J Neurooncol; 1990 Aug; 9(1):41-5. PubMed ID: 2170591
[TBL] [Abstract] [Full Text] [Related]
4. Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. brain Tumor Cooperative Group Trial 8001.
Shapiro WR; Green SB; Burger PC; Mahaley MS; Selker RG; VanGilder JC; Robertson JT; Ransohoff J; Mealey J; Strike TA
J Neurosurg; 1989 Jul; 71(1):1-9. PubMed ID: 2661738
[TBL] [Abstract] [Full Text] [Related]
